NIH-funded research U01 cooperative agreement

Using data science to understand blood cell traits and disease risk in Africa

Official title: BCX-Africa: Utilizing data science to evaluate the applicability of blood cell traits polygenic risk scores for disease prediction in Africa

Funded at Uganda Virus Research Institute · NIH-10932159 · Data updated 2026-11-12

This study is looking at genetic information from blood cells to find new genes that could help predict health risks for people of African descent, aiming to improve understanding of how genetics affect conditions like heart and infectious diseases.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUganda Virus Research Institute
NIH-funded
Lab location1 site (Entebbe, Uganda)
Project startSeptember 20, 2023
Project endJuly 31, 2026
Funding year2024
Award (this year)$247,332
NIH project number5U01HL172180-02
Project IDNIH-10932159 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals of African ancestry who are interested in understanding their genetic risk for blood-related diseases.

Less likely to help

Patients who do not have African ancestry may not benefit directly from the findings of this research.

What this research studies

This research aims to analyze existing genomic data related to blood cell traits from various initiatives across Africa to discover new genes and predict genetic risks for diseases in individuals of African ancestry. By utilizing the Open Data Science Platform, the project seeks to facilitate collaborative research in resource-limited settings. The focus is on understanding how genetic factors influence blood cell traits, which are important for various health conditions, including cardiovascular and infectious diseases. The study addresses the underrepresentation of African populations in genetic research and aims to identify population-specific genetic variants that could improve health outcomes.

Why it matters

Potential benefit: If successful, this research could lead to better disease prediction and personalized treatment strategies for individuals of African descent.

How similar studies have gone: Previous research has shown success in utilizing genomic data for disease prediction in other populations, but this approach is novel for African ancestry individuals.

Where this research is happening

  • Uganda Virus Research Institute
    Entebbe, Uganda
    Active

Researchers

  • Principal investigator: Fatumo, Segun — Uganda Virus Research Institute
  • Study coordinator: Fatumo, Segun

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.